Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease

被引:164
作者
Anderson, BE
McNiff, JM
Matte, C
Athanasiadis, I
Shlomchik, WD
Shlomchik, MJ
机构
[1] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Immunobiol Sect, Dept Dermatol,Sect Med Oncol, New Haven, CT 06520 USA
关键词
D O I
10.1182/blood-2004-01-0328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic graft-versus-host disease (cGVHD) is an increasingly common cause of morbidity and mortality in allogeneic stem cell transplantation (alloSCT). Relative to acute GVHD (aGVHD), much less is understood about cGVHD. Using the B10.D2 --> BALB/c murine cGVHD model, which shares critical pathologic features with human cGVHD, we find that radiation-resistant host T cells regulate cGVHD. We initially observed that recipients lacking all lymphocytes developed accelerated and more severe cGVHD. Using genetically deficient recipients, we determined that alphabeta(+)CD4(+) T cells were required to regulate cGVHD. Increased cGVHD severity was not due to the absence of T cells per se. Rather, the potency of regulation was proportional to host T-cell receptor (TCR) diversity. Only CD4(+)CD25(+), and not CD4(+)CD25(-), host T cells ameliorated cGVHD when added back, indicating that host T cells acted not via host-versus-graft activity or by reducing homeostatic proliferation but by an undefined regulatory mechanism. Thus, preparative regimens that spare host CD4(+)CD25(+) T cells may reduce cGVHD. Donor CD4(+)CD25(+) T cells also reduced cGVHD. Depletion of CD4(+)CD25(+) cells from the inoculum exacerbated disease, whereas transplantation of additional CD4(+)CD25(+) cells protected against severe cGVHD. Additional CD4(+)CD25(+) cells also promoted healing of established lesions, suggesting that their effects persist during the evolution of cGVHD. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:1565 / 1573
页数:9
相关论文
共 98 条
[1]   Memory CD4+ T cells do not induce graft-versus-host disease [J].
Anderson, BE ;
McNiff, J ;
Yan, J ;
Doyle, H ;
Mamula, M ;
Shlomchik, MJ ;
Shlomchik, WD .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (01) :101-108
[2]   A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections [J].
Anderson, D ;
DeFor, T ;
Burns, L ;
McGlave, P ;
Miller, J ;
Wagner, J ;
Weisdorf, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (01) :52-59
[3]   Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment [J].
Annacker, O ;
Burlen-Defranoux, O ;
Pimenta-Araujo, R ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3573-3580
[4]   Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes [J].
Annunziato, F ;
Cosmi, L ;
Liotta, F ;
Lazzeri, E ;
Manetti, R ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Romagnani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :379-387
[5]  
ATKINSON K, 1990, BLOOD, V75, P2459
[6]   Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT) [J].
Bacigalupo, A .
BONE MARROW TRANSPLANTATION, 2002, 29 (03) :191-195
[7]   T cell regulation as a side effect of homeostasis and competition [J].
Barthlott, T ;
Kassiotis, G ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :451-460
[8]   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions [J].
Blazar, BR ;
Lees, CJ ;
Martin, PJ ;
Noelle, RJ ;
Kwon, B ;
Murphy, W ;
Taylor, PA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4901-4909
[9]   Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease [J].
Blazar, BR ;
Taylor, PA ;
Panoskaltsis-Mortari, A ;
Narula, SK ;
Smith, SR ;
Roncarolo, MG ;
Vallera, DA .
TRANSPLANTATION, 1998, 66 (09) :1220-1229
[10]  
Blazar BR, 1996, J IMMUNOL, V157, P3250